Organogenesis Holdings Inc. Skyrocketed
Fri, May 10, 2024 at 10:52 PM
Organogenesis Holdings Inc. (ORGO:NASDAQ) shot up at $3.03, a gain of 32.9%. On Fri, May 10, 2024, ORGO:NASDAQ hit a New 2-Week High of $3.03. The stock appeared on our News Catalysts scanner on Fri, May 10, 2024 at 05:45 PM in the 'EARNINGS' category. From Mon, Apr 29, 2024, the stock recorded 33.33% Up Days and 50.00% Green Days
The stock spiked on Mon, Jan 08, 2024 at $4.71 with a volume of 1M+.
About Organogenesis Holdings Inc. (ORGO:NASDAQ)
Organogenesis Holdings Inc, formerly Avista Healthcare Public Acquisition Corp is a regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets.
Top 10 Gainers:
- AEye Inc. (LIDR:NASDAQ), 118.64%
- Novavax, Inc. (NVAX:NASDAQ), 98.66%
- Power REIT (PW:NYSEMKT), 57.59%
- iTeos Therapeutics Inc. (ITOS:NASDAQ), 43.07%
- Sensus Healthcare, Inc. (SRTS:NASDAQ), 38.85%
- CareDx, Inc (CDNA:NASDAQ), 34.09%
- Sweetgreen Inc. Class A (SG:NYSE), 33.96%
- Oragenics, Inc. (OGEN:NYSEMKT), 33.33%
- Organogenesis Holdings Inc. (ORGO:NASDAQ), 32.89%
- Inseego Corp. (INSG:NASDAQ), 30.99%